160 related articles for article (PubMed ID: 38751433)
1. Antibodies to
Chea S; Willen L; Nhek S; Ly P; Tang K; Oristian J; Salas-Carrillo R; Ponce A; Leon PCV; Kong D; Ly S; Sath R; Lon C; Leang R; Huy R; Yek C; Valenzuela JG; Calvo E; Manning JE; Oliveira F
Front Immunol; 2024; 15():1368066. PubMed ID: 38751433
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to
Chea S; Willen L; Nhek S; Ly P; Tang K; Oristian J; Salas-Carrillo R; Ponce A; Leon PCV; Kong D; Ly S; Sath R; Lon C; Leang R; Huy R; Yek C; Valenzuela JG; Calvo E; Manning JE; Oliveira F
medRxiv; 2023 Dec; ():. PubMed ID: 38318204
[TBL] [Abstract][Full Text] [Related]
3. Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific.
Mathieu-Daudé F; Claverie A; Plichart C; Boulanger D; Mphande FA; Bossin HC
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006660. PubMed ID: 30040826
[TBL] [Abstract][Full Text] [Related]
4. Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia.
Londoño-Rentería B; Cárdenas JC; Giovanni JE; Cárdenas L; Villamizar P; Rolón J; Chisenhall DM; Christofferson RC; Carvajal DJ; Pérez OG; Wesson DM; Mores CN
Biomedica; 2015; 35(4):572-81. PubMed ID: 26844447
[TBL] [Abstract][Full Text] [Related]
5. The PAGODAS protocol: pediatric assessment group of dengue and Aedes saliva protocol to investigate vector-borne determinants of Aedes-transmitted arboviral infections in Cambodia.
Manning JE; Oliveira F; Parker DM; Amaratunga C; Kong D; Man S; Sreng S; Lay S; Nang K; Kimsan S; Sokha L; Kamhawi S; Fay MP; Suon S; Ruhl P; Ackerman H; Huy R; Wellems TE; Valenzuela JG; Leang R
Parasit Vectors; 2018 Dec; 11(1):664. PubMed ID: 30572920
[TBL] [Abstract][Full Text] [Related]
6. Serological biomarker for assessing human exposure to Aedes mosquito bites during a randomized vector control intervention trial in northeastern Thailand.
Fustec B; Phanitchat T; Aromseree S; Pientong C; Thaewnongiew K; Ekalaksananan T; Cerqueira D; Poinsignon A; Elguero E; Bangs MJ; Alexander N; Overgaard HJ; Corbel V
PLoS Negl Trop Dis; 2021 May; 15(5):e0009440. PubMed ID: 34043621
[TBL] [Abstract][Full Text] [Related]
7. Analysis in a murine model points to IgG responses against the 34k2 salivary proteins from Aedes albopictus and Aedes aegypti as novel promising candidate markers of host exposure to Aedes mosquitoes.
Buezo Montero S; Gabrieli P; Severini F; Picci L; Di Luca M; Forneris F; Facchinelli L; Ponzi M; Lombardo F; Arcà B
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007806. PubMed ID: 31618201
[TBL] [Abstract][Full Text] [Related]
8. Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
Elanga Ndille E; Doucoure S; Poinsignon A; Mouchet F; Cornelie S; D'Ortenzio E; DeHecq JS; Remoue F
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005109. PubMed ID: 27906987
[TBL] [Abstract][Full Text] [Related]
9. Human IgG responses to the Aedes albopictus 34k2 salivary protein: analyses in Réunion Island and Bolivia confirm its suitability as marker of host exposure to the tiger mosquito.
Buezo Montero S; Gabrieli P; Poinsignon A; Zamble BZH; Lombardo F; Remoue F; Arcà B
Parasit Vectors; 2022 Jul; 15(1):260. PubMed ID: 35858924
[TBL] [Abstract][Full Text] [Related]
10. Spatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.
Sagna AB; Kassié D; Couvray A; Adja AM; Hermann E; Riveau G; Salem G; Fournet F; Remoue F
J Infect Dis; 2019 Aug; 220(7):1199-1208. PubMed ID: 31152664
[TBL] [Abstract][Full Text] [Related]
11. Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts.
Fontaine A; Pascual A; Orlandi-Pradines E; Diouf I; Remoué F; Pagès F; Fusaï T; Rogier C; Almeras L
PLoS One; 2011; 6(12):e29107. PubMed ID: 22195000
[TBL] [Abstract][Full Text] [Related]
12. Human IgG responses to Aedes mosquito salivary peptide Nterm-34kDa and its comparison to Anopheles salivary antigen (gSG6-P1) IgG responses measured among individuals living in Lower Moshi, Tanzania.
Kassam NA; Laswai D; Kulaya N; Kaaya RD; Kajeguka DC; Schmiegelow C; Wang CW; Alifrangis M; Kavishe RA
PLoS One; 2022; 17(10):e0276437. PubMed ID: 36301860
[TBL] [Abstract][Full Text] [Related]
13. IgG Antibody Responses to the
Buezo Montero S; Gabrieli P; Montarsi F; Borean A; Capelli S; De Silvestro G; Forneris F; Pombi M; Breda A; Capelli G; Arcà B
Front Cell Infect Microbiol; 2020; 10():377. PubMed ID: 32850479
[TBL] [Abstract][Full Text] [Related]
14. Non-human primate antibody response to mosquito salivary proteins: Implications for dengue virus transmission in Puerto Rico.
Hemme RR; Poole-Smith BK; Hunsperger EA; Felix GE; Horiuchi K; Biggerstaff BJ; Lopez-Ortiz R; Barrera R
Acta Trop; 2016 Dec; 164():369-374. PubMed ID: 27593498
[TBL] [Abstract][Full Text] [Related]
15. Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia.
Manning JE; Chea S; Parker DM; Bohl JA; Lay S; Mateja A; Man S; Nhek S; Ponce A; Sreng S; Kong D; Kimsan S; Meneses C; Fay MP; Suon S; Huy R; Lon C; Leang R; Oliveira F
J Infect Dis; 2022 Oct; 226(8):1327-1337. PubMed ID: 34718636
[TBL] [Abstract][Full Text] [Related]
16. Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDR.
Ndille EE; Dubot-Pérès A; Doucoure S; Mouchet F; Cornelie S; Sidavong B; Fournet F; Remoue F
Trop Med Int Health; 2014 May; 19(5):576-80. PubMed ID: 24641205
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of AeD7L2 and its physiological relevance in blood feeding in the dengue mosquito vector, Aedes aegypti.
Martin-Martin I; Kern O; Brooks S; Smith LB; Valenzuela-Leon PC; Bonilla B; Ackerman H; Calvo E
FEBS J; 2021 Mar; 288(6):2014-2029. PubMed ID: 32799410
[TBL] [Abstract][Full Text] [Related]
18. Incidence of dengue and chikungunya viruses in mosquitoes and human patients in border provinces of Vietnam.
Pham Thi KL; Briant L; Gavotte L; Labbe P; Perriat-Sanguinet M; Cornillot E; Vu TD; Nguyen TY; Tran VP; Nguyen VS; Devaux C; Afelt A; Tran CC; Phan TN; Tran ND; Frutos R
Parasit Vectors; 2017 Nov; 10(1):556. PubMed ID: 29121985
[TBL] [Abstract][Full Text] [Related]
19. Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes.
Abraham PR; R B; N PK; Kumar A
Sci Rep; 2021 Dec; 11(1):23699. PubMed ID: 34880307
[TBL] [Abstract][Full Text] [Related]
20. First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.
Elanga Ndille E; Doucoure S; Damien G; Mouchet F; Drame PM; Cornelie S; Noukpo H; Yamadjako S; Djenontin A; Moiroux N; Misse D; Akogbeto M; Corbel V; Henry MC; Chandre F; Baldet T; Remoue F
PLoS Negl Trop Dis; 2012; 6(11):e1905. PubMed ID: 23166852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
